BioLife Solutions, Inc. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
BioLife Solutions, Inc. (BLFS) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $30.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2024-11-12
- 2024-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $30.00K.
- 2024-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $36.00K.
- 2024-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $65.00K.
- 2023-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $94.00K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2024-09-30 | $30.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $36.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $65.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $94.00K 10-Q · filed 2024-11-12 |
| 2023-09-30 | $124.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.81M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $242.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $272.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $310.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $367.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $404.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $440.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $476.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $511.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $430.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $17.00K 10-K · filed 2022-03-31 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |